| pneumocystis carinii pneumonia: evolution from 1981 to 1995 in two paris hospitals. | | 1996 | 8822858 |
| biodiversity of pneumocystis carinii hominis: typing with different dna regions. | the purpose of this study was to identify the most useful gene for the detection of biodiversity of pneumocystis carinii hominis isolates and to compare samples from french and italian subjects. we studied 20 bronchoalveolar lavage fluid specimens from 20 human immunodeficiency virus-infected patients (10 french and 10 italian patients) with pneumocystis carinii pneumonia by dna sequencing of the thymidylate synthase (ts), 5s rrna, large-subunit mitochondrial rrna (mt lsu rrna), and internal tra ... | 1997 | 9003601 |
| [risk of nosocomial pneumocystis carinii pneumonia in immunosuppressed patients non-infected by human immunodeficiency viruses]. | we report four cases of pneumocystis carinii pneumonia (pcp) in human immunodeficiency virus (hiv)-seronegative patients. two of them had been hospitalized for polymyositis treatment near aids patients, respectively 1 and 4 months before pcp. the two others suffered from localized cancer. their evolution was complicated by respiratory distress and death in two of them. a telephone survey among 19 hospital units yielded nine cases of similar patients. they were only observed in wards caring for a ... | 1994 | 8059128 |
| [pneumocystis carinii pneumonia in hiv infections. committee of the 1st consensus conference of anti-infectious therapy organized in may 1990 in paris by the société de pathologie infectieuse de langue française]. | at the end of the first consensus conference on anti-infectious therapy organized by the french language society of infectious pathology in may 1990 and devoted to pneumocystosis in patients with human immunodeficiency virus (hiv) infection, the consensus committee produced this paper which answers the following 4 questions: what are the indications, technical requirements, sensitivity and benefits of induced expectoration in the diagnosis of pneumocystis carinii pneumonia? what are the initial ... | 1990 | 2100027 |
| continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe pneumocystis carinii pneumonia. | we reviewed the records of 44 patients with aids who had 45 episodes of severe pneumocystis carinii pneumonia (pcp). while 9 patients required intubation and mechanical ventilation (mv) on admission, continuous positive airway pressure (cpap) by face mask was the initial measure in 36 episodes. there were 25 patients managed with cpap alone, 23 of whom survived. among the reasons for delayed intubation and mv (11 patients) was that treatment failure was strongly associated with non-survival, sin ... | 1992 | 1644963 |
| cost effectiveness of noninvasive oxygen saturation measurement during exercise for the diagnosis of pneumocystis carinii pneumonia. | we assessed (1) the sensitivity and specificity of exercise oxygen saturation measurement (eos) for the diagnosis of pneumocystis carinii pneumonia (pcp); and (2) the cost of introducing this indirect diagnostic test compared with that of standard diagnostic strategies for pcp. in a prospective study, 85 hiv-infected patients with suspected pcp underwent eos, followed by induced sputum (is) and bronchoalveolar lavage (bal) if is was negative for p. carinii. the prevalence of pcp was 0.22, the se ... | 1993 | 8503546 |
| changes in the pattern of respiratory diseases necessitating hospitalization of hiv-infected patients since the advent of highly active antiretroviral therapy. | the incidence rates of opportunistic diseases, hospital admission and death have fallen markedly since the advent of highly active antiretroviral therapy (haart). we examined the impact of haart on the pattern of hiv-related respiratory diseases necessitating hospitalization. we retrospectively compared the numbers and etiologies of respiratory diseases diagnosed in hiv-infected patients hospitalized in the chest department of a paris university hospital during the three years preceding widespre ... | 2004 | 15765925 |
| discontinuation of primary prophylaxis for pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type i-infected patients: the changes in opportunistic prophylaxis study. | a multicenter open, randomized, controlled trial was conducted to determine whether primary prophylaxis for pneumocystis carinii pneumonia and toxoplasmic encephalitis can be discontinued in patients infected with human immunodeficiency virus type 1 (hiv-1) whose cd4+ t cell counts have increased to >200 cells/mm3 (and who have remained at this level for at least 3 months) as a result of highly active antiretroviral therapy (haart). patients were randomized to either the discontinuation arm (i.e ... | 2000 | 10823763 |
| attitudes to prevention among hiv-infected patients: the case of specific prophylaxis for pneumocystis carinii pneumonia. | despite a consensus on the need for pneumocystis carinii pneumonia (pcp) prophylaxis for hiv-infected patients with fewer than 200 cd4+ lymphocytes/mm3, the number of cases of pcp has remained stable, and about 70% involve patients who are not receiving prophylaxis. the aim of this study was to determine why these patients are not covered by prophylaxis. it was based on a retrospective analysis of semidirective interviews with 32 patients who developed pcp while not receiving prophylaxis. the re ... | 1994 | 10134582 |